Perbedaan Metro Healthcare Indonesia Tbk. dan Merck Tbk.: Metro Healthcare Indonesia Tbk. diperdagangkan di Rp426 (kapitalisasi pasar 14,23 T, volume 24 jam 124,2 rb), sedangkan Merck Tbk. diperdagangkan di Rp3.860 (kapitalisasi pasar 1,7 T, volume 24 jam 28 rb). Perbedaan utamanya: Metro Healthcare Indonesia Tbk. jauh lebih besar — sekitar 8,4× kapitalisasi pasar Merck Tbk., dan Metro Healthcare Indonesia Tbk. lebih aktif diperdagangkan (124,2 rb vs 28 rb). Mana yang lebih baik tergantung tujuan investasimu.
| CARE | MERK | |
|---|---|---|
Kapitalisasi Pasar | 14,23 T | 1,7 T |
Volume | 124,2 rb | 28 rb |
Lot | 1,24 rb | 280 |
Perputaran | 53,03 jt | 107,47 jt |
Harga Rata-rata | 427,01 | 3.838,25 |
Nilai Transaksi | 53,03 jt | 107,47 jt |
Harga Ekuilibrium Indikatif | 428 | 3.850 |
Volume Ekuilibrium Indikatif | 400 | 1 |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Metro Healthcare Indonesia Tbk (the “Company”) was established under the name PT Aruna Anjaya Perkasa, based on Notarial Deed No. 67 dated October 07, 2015 of Humberg Lie, S.H., S.E., M.Kn notary in Jakarta. The Company started its commercial operations in 2016 .
Selengkapnya di halaman CARE →PT Merck Tbk (the Company) is domiciled in Indonesia and located at Jl. TB Simatupang No. 8, Pasar Rebo, East Jakarta, was established in framework of Law No. 1 of 1967 and Law No. 11 of 1970 on foreign capital investment by deed of notary public Eliza Pondaag, SH dated 14 October 1970 No. 29. PT Merck Indonesia is a member of the Merck International Group. The company produces pharmaceutical products with production facility in East Jakarta. It commenced its operation in 1974 in manufacturing medical products, such as Songobian and Neurobion.
Selengkapnya di halaman MERK →